MIRA INFORM REPORT

 

 

Report Date :

30.08.2014

           

IDENTIFICATION DETAILS

 

Name :

BILIM ILAC SANAYII VE TICARET A.S.

 

 

Registered Office :

Kaptanpasa Mah. Zincirlikuyu Cad. No:184 Beyoglu Istanbul

 

 

Country :

Turkey

 

 

Financials (as on) :

31.12.2012

 

 

Date of Incorporation :

04.05.1961

 

 

Com. Reg. No.:

79251

 

 

Legal Form :

Joint Stock Company

 

 

Line of Business :

Manufacture and trade of medicine.

 

 

No. of Employees

2.100

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Status :

Satisfactory

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 1, 2014

 

Country Name

Previous Rating

(31.03.2014)

Current Rating

(01.06.2014)

Turkey

B1

B1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 


 

TURKEY - ECONOMIC OVERVIEW

 

Turkey's largely free-market economy is increasingly driven by its industry and service sectors, although its traditional agriculture sector still accounts for about 25% of employment. An aggressive privatization program has reduced state involvement in basic industry, banking, transport, and communication, and an emerging cadre of middle-class entrepreneurs is adding dynamism to the economy and expanding production beyond the traditional textiles and clothing sectors. The automotive, construction, and electronics industries are rising in importance and have surpassed textiles within Turkey's export mix. Oil began to flow through the Baku-Tbilisi-Ceyhan pipeline in May 2006, marking a major milestone that will bring up to 1 million barrels per day from the Caspian to market. Several gas pipelines projects also are moving forward to help transport Central Asian gas to Europe through Turkey, which over the long term will help address Turkey's dependence on imported oil and gas to meet 97% of its energy needs. After Turkey experienced a severe financial crisis in 2001, Ankara adopted financial and fiscal reforms as part of an IMF program. The reforms strengthened the country's economic fundamentals and ushered in an era of strong growth averaging more than 6% annually until 2008. Global economic conditions and tighter fiscal policy caused GDP to contract in 2009, but Turkey's well-regulated financial markets and banking system helped the country weather the global financial crisis and GDP rebounded strongly to around 9% in 2010-11, as exports returned to normal levels following the recession. Growth dropped to roughly 3-4% in 2012-13. Turkey's public sector debt to GDP ratio has fallen below 40%, and two rating agencies upgraded Turkey's debt to investment grade in 2012 and 2013. Turkey remains dependent on often volatile, short-term investment to finance its large current account deficit. The stock value of FDI reached nearly $195 billion at year-end 2013, reflecting Turkey's robust growth even in the face of economic turmoil in Europe, the source of much of Turkey's FDI. Turkey's relatively high current account deficit, domestic political uncertainty, and turmoil within Turkey's neighborhood leave the economy vulnerable to destabilizing shifts in investor confidence.

Source : CIA

 

 

 


COMPANY IDENTIFICATION

 

NAME

:

BILIM ILAC SANAYII VE TICARET A.S.

HEAD OFFICE ADDRESS

:

Kaptanpasa Mah. Zincirlikuyu Cad. No:184 Beyoglu Istanbul / Turkey

PHONE NUMBER

:

90-212-365 15 00 (Pbx)

 

FAX NUMBER

:

90-212-276 29 19

90-212-286 40 97

 

WEB-ADDRESS

:

www.bilimilac.com.tr

E-MAIL

:

info@bilimilac.com.tr

 

 

LEGAL STATUS AND HISTORY

 

TAX OFFICE

:

Buyuk Mukellefler

TAX NO

:

1750002098

REGISTRATION NUMBER

:

79251

REGISTERED OFFICE

:

Istanbul Chamber of Commerce

DATE ESTABLISHED

:

04.05.1961

LEGAL FORM

:

Joint Stock Company

TYPE OF COMPANY

:

Private

REGISTERED CAPITAL

:

TL   29.487.676,40

HISTORY

:

Previous Registered Capital

:

TL 12.000.000

Changed On

:

28.04.2008 (Commercial Gazette Date /Number 01.05.2008/ 7053)

Previous Registered Capital

:

TL 29.000.000

Changed On

:

27.12.2013 (Commercial Gazette Date /Number 03.01.2014/ 8478)

Previous Address

:

Maslak Mah. Sumer Sok. No:4 Sisli - Istanbul (former name:Ayazaga Koyu Yolu G-42 Sok. No:6 Maslak - Istanbul)

Changed On

:

21.05.2013 (Commercial Gazette Date /Number 24.05.2013/ 8327)

Merger

:

The subject took over and merged with "Bilfar Holding A.S." and "Urfar Ilac Sanayi ve Ticaret A.S."

Changed On

:

27.12.2013 (Commercial Gazette Date /Number 03.01.2014/ 8478)

 

OWNERSHIP / MANAGEMENT

 

SHAREHOLDERS

:

Bulent Karaagac

55,69 %

Mustafa Kemal Karaagac

36,75 %

Soydan Karaagac

2,14 %

Mina Karaagac

1,06 %

Fatma Erten Basaran

1,06 %

Serra Karaagac

1,06 %

Esra Karaagac

1,06 %

Kladua Ergene

 

Gulseren Karaagac

 

Mehmet Adil Karaagac

 

Others

 

 

 

GROUP PARENT COMPANY

:

BILFAR GROUP OF COMPANIES       

 

SISTER COMPANIES

:

AKTIF KOZMETIK SATIS PAZARLAMA VE DAGITIM A.S.

CONSENTIS ILAC SANAYI VE TICARET LTD. STI.

GENERICA ILAC SANAYI VE TICARET A.S.

HUSNU ARSAN ILACLARI A.S.

KAR GAYRIMENKUL GELISTIRME VE INSAAT A.S.

KAR KOZMETIK URUNLER TICARET PAZARLAMA VE SANAYI A.S.

KOPAS KOZMETIK PAZARLAMA VE SANAYI A.S.

 

BOARD OF DIRECTORS

:

Bulent Karaagac

Chairman

Mustafa Kemal Karaagac

Vice-Chairman

Serdar Tamer Kaygan

Member

Erhan Bas

Member

 

 

DIRECTORS

:

Erhan Bas

General Manager

 

 

OPERATIONS

 

BUSINESS ACTIVITIES

:

Manufacture and trade of medicine.

 

NACE CODE

:

DG.24.41

 

SECTOR

:

Chemicals

 

NUMBER OF EMPLOYEES

:

2.100

 

NET SALES

:

4.358 TL Thousand

(1996) 

8.397 TL Thousand

(1997) 

17.337 TL Thousand

(1998) 

31.798 TL Thousand

(1999) 

47.697 TL Thousand

(2000) 

80.507 TL Thousand

(2001) 

125.632 TL Thousand

(2002) 

150.616 TL Thousand

(2003) 

185.131 TL Thousand

(2004) 

238.643 TL Thousand

(2005) 

300.270 TL Thousand

(2006) 

344.139 TL Thousand

(2007) 

404.102 TL Thousand

(2008) 

469.633 TL Thousand

(2009) 

489.248.419 TL

(2010) 

567.001.542 TL

(2011) 

587.716 TL Thousand

(2012) 

595.841 TL Thousand

(2013) 

 

 

IMPORT COUNTRIES

:

Italy

Netherlands

Spain

Austria

Japan

India

Switzerland

U.S.A.

 

MERCHANDISE IMPORTED

:

Raw materials of medicine

Wrapping paper

 

EXPORT VALUE

:

133 TL Thousand

(1996)

43 TL Thousand

(1997)

293 TL Thousand

(1998)

457 TL Thousand

(1999)

586 TL Thousand

(2000)

3.471 TL Thousand

(2001)

7.159 TL Thousand

(2002)

9.748 TL Thousand

(2003)

11.582 TL Thousand

(2004)

12.636 TL Thousand

(2005)

11.334 TL Thousand

(2006)

14.713 TL Thousand

(2007)

19.080.000 USD

(2008)

22.659 USD Thousand

(2009)

44.104.763 TL

(2010)

29.575 USD Thousand

(2011)

72.797 TL Thousand

(2012)

45.838 USD Thousand

(2013)

 

 

EXPORT COUNTRIES

:

Iraq

Belgium

Azerbaijan

Malaysia

France

Yemen

Netherlands

Afghanistan

Georgia

Libya

Malta

U.A.E.

Hong-Kong

Macedonia Republic

Somalia

Philippines

Guatamela

Kenya

 

MERCHANDISE  EXPORTED

:

Medicine

 

HEAD OFFICE ADDRESS

:

Kaptanpasa Mah. Zincirlikuyu Cad. No:184 Beyoglu  Istanbul / Turkey

 

BRANCHES

:

Factory  :  Cerkezkoy Organize Sanayi Bolgesi Cerkezkoy Tekirdag/Turkey (owned) (22.800 sqm)

 

Factory  :  Gebze Organize Sanayi Bolgesi Gebze Kocaeli/Turkey

 

 

TREND OF BUSINESS

:

There was a slowdown at business volume in real terms in  2013.

SIZE OF BUSINESS

:

Giant

 

 

FINANCE

 

MAIN DEALING BANKS

:

Akbank Istanbul Kurumsal Branch

HSBC Bank Merkez Branch

ING Bank Merkez Branch

T. Is Bankasi Maslak Kurumsal Branch

Yapi ve Kredi Bankasi Esentepe Branch

 

PAYMENT BEHAVIOUR

:

No payment delays have come to our knowledge.

 

KEY FINANCIAL ELEMENTS

:

 

(2012) TL Thousand

(2013) TL Thousand

 

 

 

Net Sales

587.716

595.841

 

 

 

Profit (Loss) Before Tax

78.821

37.297

 

 

 

Stockholders' Equity

356.961

338.955

 

 

 

Total Assets

548.432

1.043.000

 

 

 

Current Assets

328.629

 

 

 

 

Non-Current Assets

219.803

 

 

 

 

Current Liabilities

89.959

 

 

 

 

Long-Term Liabilities

101.512

 

 

 

 

Gross Profit (loss)

298.176

 

 

 

 

Operating Profit (loss)

79.616

 

 

 

 

Net Profit (loss)

65.734

 

 

 

 

 

 

 

 

COMMENT ON FINANCIAL POSITION

 

Capitalization

Fair As of 31.12.2013

Profitability

High Operating Profitability  in 2012

High Net Profitability  in 2012

Good Net Profitability  in 2013

 

General Financial Position

Fair

 

 

 

Incr. in producers’ price index

 

Average USD/TL

Average EUR/TL

Average GBP/ TL

 ( 2001 )

88,60 %

1,1991

1,0714

1,7300

 ( 2002 )

30,80 %

1,5168

1,3741

2,2001

 ( 2003 )

13,90 %

1,5302

1,7141

2,4982

 ( 2004 )

13,84 %

1,4266

1,7666

2,6001

 ( 2005 )

2,66 %

1,3499

1,6882

2,4623

 ( 2006 )

11,58 %

1,4309

1,7987

2,6377

 ( 2007 )

5,94 %

1,3075

1,7901

2,6133

 ( 2008 )

8,11 %

1,2858

1,8876

2,3708

 ( 2009 )

5,93 %

1,5460

2,1529

2,4094

 ( 2010 )

8,87 %

1,5128

2,0096

2,3410

 ( 2011 )

13,33 %

1,6797

2,3378

2,6863

 ( 2012 )

2,45 %

1,7995

2,3265

2,8593

 ( 2013 )

6,97 %

1,9179

2,5530

3,0178

 ( 01.01-31.07.2014)

5,89 %

2,1578

2,9492

3,6152

 

BALANCE SHEETS

 

 

 ( 31.12.2012 )  TL Thousand

 

CURRENT ASSETS

328.629

0,60

Not Detailed Current Assets

0

0,00

Cash and Banks

6.988

0,01

Marketable Securities

0

0,00

Account Receivable

247.620

0,45

Other Receivable

1

0,00

Inventories

65.221

0,12

Advances Given

381

0,00

Accumulated Construction Expense

0

0,00

Other Current Assets

8.418

0,02

NON-CURRENT ASSETS

219.803

0,40

Not Detailed Non-Current Assets

0

0,00

Long-term Receivable

52

0,00

Financial Assets

392

0,00

Tangible Fixed Assets (net)

201.159

0,37

Intangible Assets

18.170

0,03

Deferred Tax Assets

0

0,00

Other Non-Current Assets

30

0,00

TOTAL ASSETS

548.432

1,00

CURRENT LIABILITIES

89.959

0,16

Not Detailed Current Liabilities

0

0,00

Financial Loans

32.287

0,06

Accounts Payable

41.003

0,07

Loans from Shareholders

141

0,00

Other Short-term Payable

609

0,00

Advances from Customers

435

0,00

Accumulated Construction Income

0

0,00

Taxes Payable

11.765

0,02

Provisions

3.598

0,01

Other Current Liabilities

121

0,00

LONG-TERM LIABILITIES

101.512

0,19

Not Detailed Long-term Liabilities

0

0,00

Financial Loans

84.350

0,15

Securities Issued

0

0,00

Long-term Payable

0

0,00

Loans from Shareholders

0

0,00

Other Long-term Liabilities

0

0,00

Provisions

17.162

0,03

STOCKHOLDERS' EQUITY

356.961

0,65

Not Detailed Stockholders' Equity

0

0,00

Paid-in Capital

29.000

0,05

Cross Shareholding Adjustment of Capital

0

0,00

Inflation Adjustment of Capital

32.546

0,06

Equity of Consolidated Firms

0

0,00

Reserves

229.681

0,42

Revaluation Fund

0

0,00

Accumulated Losses(-)

0

0,00

Net Profit (loss)

65.734

0,12

TOTAL LIABILITIES AND EQUITY

548.432

1,00

 

REMARKS ON FINANCIAL STATEMENT

:

At the financial statements according to TAS, "Cheques Received" and "Outstanding Cheques" figures are under "Cash And Banks" figure. Beginning from the financial statements of 31.12.2011, "Cheques Received" and "Outstanding Cheques" figures are given under "Account Receivable" figure and "Account Payable" figure respectively. 

 

In the sub-items of "Account Receivable", TL thousand 1.056 is "Doubtful Trade Receivables" and -TL thousand 1.056 is "Provision for Doubtful Trade Receivables" at the last balance sheet. 

 

The details of "Other Receivable" figure at the last balance sheet (TL Thousand): Due From Shareholders: 0, Due From Participations: 0, Due From Affiliated Companies: 0, Due From Personnel: 0, Other Miscellaneous Receivables: 1, Other Receivable Total: 1

 

 TL thousand 0 of "Tax Payable" is due to "Overdue, Delayed or Deferred Tax by Installments and Other Liabilities" at the last balance sheet.

 

 At the last income statement TL thousand 22.526 of the other income is due to "Profit from Foreign Currency Exchange".

 

 

INCOME STATEMENT

 

 

(2012) TL Thousand

 

Net Sales

587.716

1,00

Cost of Goods Sold

289.540

0,49

Gross Profit

298.176

0,51

Operating Expenses

218.560

0,37

Operating Profit

79.616

0,14

Other Income

38.814

0,07

Other Expenses

19.730

0,03

Financial Expenses

19.879

0,03

Minority Interests

0

0,00

Profit (loss) of consolidated firms

0

0,00

Profit (loss) Before Tax

78.821

0,13

Tax Payable

13.087

0,02

Postponed Tax Gain

0

0,00

Net Profit (loss)

65.734

0,11

 

 

FINANCIAL RATIOS

 

 

(2012)

LIQUIDITY RATIOS

 

Current Ratio

3,65

Acid-Test Ratio

2,83

Cash Ratio

0,08

ASSET STRUCTURE RATIOS

 

Inventory/Total Assets

0,12

Short-term Receivable/Total Assets

0,45

Tangible Assets/Total Assets

0,37

TURNOVER RATIOS

 

Inventory Turnover

4,44

Stockholders' Equity Turnover

1,65

Asset Turnover

1,07

FINANCIAL STRUCTURE

 

Stockholders' Equity/Total Assets

0,65

Current Liabilities/Total Assets

0,16

Financial Leverage

0,35

Gearing Percentage

0,54

PROFITABILITY RATIOS

 

Net Profit/Stockholders' Eq.

0,18

Operating Profit Margin

0,14

Net Profit Margin

0,11

Interest Cover

4,97

COLLECTION-PAYMENT

 

Average Collection Period (days)

151,71

Average Payable Period (days)

50,98

WORKING CAPITAL

238670,00

 


 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.60.44

UK Pound

1

Rs.98.64

Euro

1

Rs.78.20

                

INFORMATION DETAILS

 

Analysis Done by :

SUM

 

 

Report Prepared by :

SDA

               

RATING EXPLANATIONS

 

RATING

STATUS

PROPOSED CREDIT LINE

 

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

 

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

 

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

 

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

 

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

 

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

 

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

Credit not recommended

 

--

NB

New Business

--

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.